SynPlexity
Transforming synthetic biology with precise, cost-effective gene libraries.
- Headquarters
- Eugene, Oregon
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- synplexity.com
- Total Funding
- $520K
About
SynPlexity enables researchers to scale biology with multiplexed DNA libraries — delivering more variants, faster discovery, and lower cost using proprietary DropSynth microreactor technology. The platform serves protein engineering, drug discovery, and functional genomics workflows, providing gene libraries up to 25,000+ fragments with in-house NGS quality control.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account